Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 22, 2022
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
[ Thu, Sep 22nd 2022
] - WOPRAI
Kalpit Patel Maintained (ALLO) at Strong Buy with Decreased Target to $18 on, Sep 22nd, 2022
Kalpit Patel of B. Riley Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $21 to $18 on, Sep 22nd, 2022.
Kalpit has made no other calls on ALLO in the last 4 months.
There are 5 other peers that have a rating on ALLO. Out of the 5 peers that are also analyzing ALLO, 2 agree with Kalpit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Dane Leone of "Raymond James" Downgraded from Buy to Hold on, Wednesday, August 10th, 2022
- Jack Allen of "Baird" Initiated at Hold and Held Target at $11 on, Friday, June 3rd, 2022
These are the ratings of the 3 analyists that currently disagree with Kalpit
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $32 on, Wednesday, August 10th, 2022
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 10th, 2022
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $32 on, Friday, July 15th, 2022
